Literature DB >> 25192768

Nuclear proteasomes carry a constitutive posttranslational modification which derails SDS-PAGE (but not CTAB-PAGE).

David S Pitcher1, Kate de Mattos-Shipley1, Ziming Wang1, Konstantinos Tzortzis1, Katerina Goudevenou1, Helen Flynn2, Georg Bohn1, Amin Rahemtulla1, Irene Roberts1, Ambrosius P Snijders2, Anastasios Karadimitris1, Maurits F Kleijnen3.   

Abstract

We report that subunits of human nuclear proteasomes carry a previously unrecognised, constitutive posttranslational modification. Subunits with this modification are not visualised by SDS-PAGE, which is used in almost all denaturing protein gel electrophoresis. In contrast, CTAB-PAGE readily visualises such modified subunits. Thus, under most experimental conditions, with identical samples, SDS-PAGE yielded gel electrophoresis patterns for subunits of nuclear proteasomes which were misleading and strikingly different from those obtained with CTAB-PAGE. Initial analysis indicates a novel modification of a high negative charge with some similarity to polyADP-ribose, possibly explaining compatibility with (positively-charged) CTAB-PAGE but not (negatively-charged) SDS-PAGE and providing a mechanism for how nuclear proteasomes may interact with chromatin, DNA and other nuclear components.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ADP-ribose; Apoptosis; CTAB-PAGE; Nuclear biology; Proteasome; Ubiquitin

Year:  2014        PMID: 25192768     DOI: 10.1016/j.bbapap.2014.08.013

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

1.  Proteasome inhibition by bortezomib: A left hook and a right punch.

Authors:  Jeroen Roelofs
Journal:  EBioMedicine       Date:  2015-07-08       Impact factor: 8.143

2.  Bortezomib Amplifies Effect on Intracellular Proteasomes by Changing Proteasome Structure.

Authors:  David S Pitcher; Kate de Mattos-Shipley; Konstantinos Tzortzis; Holger W Auner; Anastasios Karadimitris; Maurits F Kleijnen
Journal:  EBioMedicine       Date:  2015-05-28       Impact factor: 8.143

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.